Even higher sensitivity (90%) was observed for discrimination between active IBD and IBS/healthy controls, which is in line with strong positive correlations observed between BAFF and disease activity, TNF-α and IL-1β in patients with UC. The gene discussed is TNFSF13B; the disease is irritable bowel syndrome.